Insulin Degludec/Liraglutide Efficacy Investigated for Glycemic Control in T2D Patients on GLP-1RA + OADs
The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
Abstract
Insulin degludec/liraglutide efficacy is being investigated for glycemic control in adults with Type 2 Diabetes inadequately controlled on GLP-1RA and OAD therapy.